Author: Rylee Wilson

Recent research on Medicare Advantage has tracked competition in local markets and investigated the rates of biosimilar drug uptake in both MA and traditional Medicare. 

UnitedHealth group has the largest Medicare Advantage market share in 25 states, according to the American Medical Association. 

CMS rejected around a third of proposed Medicare Advantage television ads in 2023, Politico reported Jan. 5. 

CVS Health beat its expectations for growth during Medicare Advantage open enrollment, the company said. 

Blue Cross Blue Shield of Alabama has more than 90% of the commercial and exchange insurance market share in three cities in the state, the most highly concentrated markets in the U.S., according to the American Medical Association. 

Several mergers and acquisitions are afoot in Medicare Advantage. 

Elevance Health plans to acquire Paragon Healthcare, which operates infusion centers and specialty pharmacies. 

Medicare Advantage beneficiaries are more likely to be prescribed biosimilar drugs than their counterparts in traditional Medicare, a study published Dec. 28 in JAMA Health Forum found. 

Cigna is nearing a deal to sell its Medicare Advantage business to Health Care Service Corp., the Wall Street Journal reported Jan. 3. 

Blue Shield of California will lay off 140 employees at the end of January, according to a notice the company filed with California's economic development department Dec. 29.